Meta-analysis of immune epitope data for all Plasmodia: Overview and applications for malarial immunobiology and vaccine-related issues

Parasite Immunology

Volumn 31, Issue 2, 2009, Pages 78-97

  Vaughan, K ^a   Blythe, M ^a   Greenbaum, J ^a   Zhang, Q ^a   Peters, B ^a   Doolan, D L ^b   Sette, A ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Epitope; Malaria; Plasmodium; Vaccine

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LIPOPROTEIN; MALARIA VACCINE; PARASITE ANTIGEN; PEPTIDE;

ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOREACTIVITY; MALARIA; NONHUMAN; OUTCOME ASSESSMENT; PARASITE DEVELOPMENT; PATHOGENESIS; PHENOTYPE; PLASMODIUM; PRIORITY JOURNAL; PROTOZOAL GENETICS; REVIEW; STRAIN DIFFERENCE; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNITY, ACTIVE; LIFE CYCLE STAGES; MALARIA; MALARIA VACCINES; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM; RABBITS;

EID: 58249123381     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2008.01077.x     Document Type: Review

References (59)

1. WHO World Malaria Report : http://www.who.int/malaria/wmr2008/ malaria2008.
2. Smith JD Deitsch KW. Pregnancy-associated malaria and the prospects for syndrome-specific anti-malaria vaccines. J Exp Med 2004 200 : 1093 1097.
3. Snow RW, Guerra CA, Noor AM, et al. The global distribution of clinical episode of Plasmodium falciparum malaria. Nature 2005 434 : 214 217.
4. Marsh K Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006 28 : 51 60.
5. Schofield L Mueller I. Clinical immunity to malaria. Curr Mol Med 2006 6 : 205 221.
6. Bloland P. Drug resistance in malaria. WHO report 2001. WHO Department of Communicable Disease Surveillance and Response. Available at: < http://www.who.int/emc >.
7. Greenwood BM, Fidock DA, Kyle DE, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest 2008 118 : 1266 1276.
8. Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002 419 : 498 511.
9. Komisar JL. Malaria vaccines. Front Biosci 2007 12 : 3928 3955.
10. Hill AS. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nature Immunol 2006 6 : 21 32.
11. Epstein JE, Giersing B, Mullen G, Moorthy V Richie T. Malaria vaccines: are we getting closer? Curr Opin Mol Ther 2007 9 : 12 24.
12. Alonso PL, Sacarlal J, Aponte JJ, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005 366 : 2012 2018.
13. Alonso PL. Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind. Int Microbiol 2006 9 : 83 93.
14. Vekemans J Ballou WR. Plasmodium falciparum malaria vaccines in development. Expert Rev Vaccines 2008 7 : 223 240.
15. Malkin EM, Diemert DJ, McArthur JH, et al. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 2005 73 : 3677 3685.
16. Doolan DL Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 2006 6 : 169 185.
17. Good MF, Xu H, Wykes M Engwerda CR. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005 23 : 69 99.
18. Wipasa J Riley EM. The immunological challenges of malaria vaccine development. Expert Opin Biol Ther 2007 7 : 1841 1852.
19. Langhorne J, Ndungu FM, Sponaas AM Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008 9 : 725 732.
20. Tuteja R. Malaria: an overview. FEBS J 2007 274 : 4670 4679.
21. Bui HH, Peters B, Assarsson E, Mbawuike I Sette A. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 2007 104 : 246 251.
22. Blythe M, Zhang Q, Vaughan K, et al. An analysis of the epitope knowledge related to Mycobacteria. Immunome Res 2007 3 : 10.
23. Zarebski L, Vaughan K, Sidney J, et al. Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Rev Vaccines 2008 7 : 55 74.
24. Dieckmann-Schuppert A, Bender S, Odenthal-Schnittler M, Bause E Schwarz RT. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem 1992 205 : 815 825.
25. Gowda DC Davidson EA. Protein glycosylation in the malaria parasite. Parasitol Today 1999 15 : 147 152.
26. Schofield L. Rational approaches to developing an anti-disease vaccine against malaria. Microbes Infect 2007 9 : 784 791.
27. Doolan DL Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000 165 : 1453 1562.
28. Wang R, Doolan DL, Le TP, et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998 282 : 476 480.
29. Wang R, Epstein J, Baraceros FM, et al. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA 2001 98 : 10817 10822.
30. + T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. J Immunol 2004 172 : 5561 5569.
31. Hill AVS, Allsop CEM, Kwiatkowski D, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991 352 : 595 600.
32. Hill AS, Elvin J, Willis AC, et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992 360 : 434 439.
33. Feng ZP, Zhang X, Han P, Arora N, Anders RF Norton RS. Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Mol Biochem Parasitol 2006 150 : 256 267.
34. Malaria: Parasite biology, pathogenesis and protection. (ed. Sherman IW) Washington, DC, ASM Press, 1998.
35. Su Z Stevenson MM. IL-12 is required for antibody-mediated protective immunity against blood stage Plasmodium chabaudi AS malaria. J Immunol 2002 168 : 1348 1355.
36. Desowitz RS. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria. Trans R Soc Trop Med Hyg 1989 83 : 478 479.
37. Desowitz RS, Elm J Alpers M. Plasmodium falciparum-specific immunoglobulin G (IgG), IgM and IgE antibodies in paired maternal-cord sera from East Sepik Province, Papua New Guinea. Infect Immun 1993 61 : 988 993.
38. Duarte J, Deshpande P, Guiyedi V, et al. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malaria J 2007 6 : 1 13.
39. Troye-Blomberg M, Riley EM, Perlmann H, et al. T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol 1989 143 : 3043 3048.
40. Langhorne J, Cross C, Seixas E, Li C Von der Weid T. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci 1998 95 : 1730 1734.
41. Joshi SK, Bharadwaj A, Chatterjee S Chauhan VS. Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India. Infect Immun 2000 68 : 141 150.
42. Wykes M Good M. Memory B cell responses and malaria. Parasite Immunol 2006 28 : 31 34.
43. b mice. J Immunol 1986 137 : 2956 2960.
44. Kulane A, Siddique AB, Perlmann H, et al. T- and B-cell responses of malaria immune individuals to synthetic peptides corresponding to non-repeat sequences in the N-terminal region of the Plasmodium falciparum antigen Pf155/RESA. Acta Trop 1997 68 : 37 51.
45. Ssewanyana I, Pietras C, Baker CR, et al. Pattern of malaria-specific T-cell responses in a cohort of Ugandan children. J Trop Ped 2007 54 : 6 13.
46. Kumar KA, Sano G, Boscardin S, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature Lett 2006 444 : 937.
47. Mehlin C, Boni E, Buckner FS, et al. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol 2006 148 : 144 160.
48. Vedadi M, Lew J, Artz J, et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol 2007 151 : 100 110.
49. Tsuboi T, Takeo S, Iriko H, et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 2008 76 : 1702 1708.
50. Bahl A, Brunk B, Crabtree J, et al. PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res 2003 31 : 212 215.
51. Egan AF, Fabucci ME, Saul A, Kaslow DC Miller LH. Aotus New World monkeys: model for studying malaria-induced anemia. Blood 2002 99 : 3863 3866.
52. Gilks CF, Walliker D Newbold CI. Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi:- a rodent malaria model. Parasite Immunol 1990 12 : 45 64.
53. Mota MM, Jarra W, Hirst E, Patnaik PK Holder AA. Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way. Infect Immun 2000 68 : 4135 4144.
54. Weiss L, Johnson J Weidanz W. Mechanisms of splenic control of murine malaria: tissue culture studies of the erythrocytic interplay of spleen, bone marrow and blood in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice. AM J Trop Med Hyg 1989 41 : 135 143.
55. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B Hoffman SL. Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis 1998 178 : 592 595.
56. Eisen DP, Wang L, Jouin H, et al. Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals. Malaria J 2007 6 : 86.
57. Cox-Singh J, Davis T, Kin-Sung L, et al. Plasmodium knowlesi malaria in human is widely distributed and potentially life threatening. Clin Infect Dis 2007 46 : 165.
58. White NJ. Sharing malarias. Lancet 2004 363 : 1006.
59. White NJ. Plasmodium knowlesi: The fifth human malaria parasite. Clin Infect Dis 2008 46 : 172.